Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study
Main Authors: | D Vasudevan, Manoj M Naik, Qayum I Mukaddam |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Annals of Indian Academy of Neurology |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2014;volume=17;issue=4;spage=480;epage=481;aulast=Vasudevan |
Similar Items
-
Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study
by: D Vasudevan, et al.
Published: (2014-01-01) -
Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
by: Dongre YU, et al.
Published: (2013-05-01) -
Randomized study to compare the effect of pregabalin with fixed-drug combination of pregabalin and methylcobalamin in the patients of postherpetic neuralgia
by: Asmita Jha, et al.
Published: (2018-01-01) -
Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
by: Martinez Jose A, et al.
Published: (2012-01-01) -
A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
by: A Srivastava, et al.
Published: (2012-01-01)